BASIS OF PRESENTATION (Details Narrative) - USD ($) |
3 Months Ended | 12 Months Ended | |||||
---|---|---|---|---|---|---|---|
Sep. 30, 2024 |
Sep. 23, 2024 |
May 22, 2024 |
Apr. 22, 2024 |
Mar. 29, 2025 |
Mar. 30, 2024 |
Dec. 28, 2024 |
|
Net losses | $ 3,113,533 | $ 32,548,215 | $ 43,900,000 | ||||
Net cash outflows from operations | 3,414,201 | 3,106,950 | 14,200,000 | ||||
Sale of prefunded warrant | 2,405,000 | 37,550,000 | |||||
Net proceeds | $ 33,900,000 | ||||||
Litigation | $ 5,100,000 | ||||||
Legal settlements | $ 19,700,000 | ||||||
Pre-judgment interest | $ 10,800,000 | ||||||
Attorneys fees and costs | $ 10,200,000 | ||||||
Common Stock [Member] | |||||||
Net losses | |||||||
Sale of prefunded warrant | 43,000,000.0 | ||||||
Warrant [Member] | |||||||
Sale of prefunded warrant | 4,000,000.0 |
X | ||||||||||
- Definition The amount of expense provided in the period for legal costs incurred on or before the balance sheet date pertaining to resolved, pending or threatened litigation, including arbitration and mediation proceedings. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of loss from litigation settlement for amount awarded to other party. Excludes claims within an insurance entity's normal claims settlement process. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The portion of profit or loss for the period, net of income taxes, which is attributable to the parent. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition The amount of cash paid for the settlement of litigation or for other legal issues during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount of asset related to consideration paid in advance for interest that provides economic benefits within a future period of one year or the normal operating cycle, if longer. Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
X | ||||||||||
- Definition The cash inflow from the additional capital contribution to the entity. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition The number of shares issued or sold by the subsidiary or equity method investee per stock transaction. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|